These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27302771)

  • 1. TIMP-1 expression induced by IL-32 is mediated through activation of AP-1 signal pathway.
    Xu H; Zhang S; Pan X; Cao H; Huang X; Xu Q; Zhong H; Peng X
    Int Immunopharmacol; 2016 Sep; 38():233-7. PubMed ID: 27302771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells.
    Nee LE; McMorrow T; Campbell E; Slattery C; Ryan MP
    Kidney Int; 2004 Oct; 66(4):1376-86. PubMed ID: 15458430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 Can Promote the Process of Pulmonary Fibrosis by Inducing the Imbalance Between MMP-9 and TIMP-1.
    Wu L; Luo Z; Zheng J; Yao P; Yuan Z; Lv X; Zhao J; Wang M
    Inflammation; 2018 Jun; 41(3):878-885. PubMed ID: 29417309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis.
    Lachowski D; Cortes E; Rice A; Pinato D; Rombouts K; Del Rio Hernandez A
    Sci Rep; 2019 May; 9(1):7299. PubMed ID: 31086224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP-1 mediates the inhibitory effect of interleukin-6 on the proliferation of a hepatocarcinoma cell line in a STAT3-dependent manner.
    Guo SY; Shen X; Yang J; Yuan J; Yang RL; Mao K; Zhao DH; Li CJ
    Braz J Med Biol Res; 2007 May; 40(5):621-31. PubMed ID: 17464423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR; Kim CH
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
    Arthur MJ; Mann DA; Iredale JP
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S33-8. PubMed ID: 9792032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
    Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of interleukin-1β-induced proliferation in rat hepatic stellate cells from different levels of signal transduction.
    Yaping Z; Ying W; Luqin D; Ning T; Xuemei A; Xixian Y
    APMIS; 2014 May; 122(5):392-8. PubMed ID: 23992404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
    Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
    Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
    Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice.
    Thiele ND; Wirth JW; Steins D; Koop AC; Ittrich H; Lohse AW; Kluwe J
    Sci Rep; 2017 Apr; 7(1):714. PubMed ID: 28386095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma.
    Song T; Dou C; Jia Y; Tu K; Zheng X
    Oncotarget; 2015 May; 6(14):12061-79. PubMed ID: 25909286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
    Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
    J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms.
    Aoki T; Kataoka H; Moriwaki T; Nozaki K; Hashimoto N
    Stroke; 2007 Aug; 38(8):2337-45. PubMed ID: 17569872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
    Badra G; Lotfy M; El-Refaie A; Obada M; Abdelmonem E; Kandeel S; Fathy A
    Acta Microbiol Immunol Hung; 2010 Mar; 57(1):29-42. PubMed ID: 20350877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice.
    Roderfeld M; Weiskirchen R; Wagner S; Berres ML; Henkel C; Grötzinger J; Gressner AM; Matern S; Roeb E
    FASEB J; 2006 Mar; 20(3):444-54. PubMed ID: 16507762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.